Pepticore

Antibacterial and Antifungal Drug Development

Health Tech & Life Sciences
Active
Pre-Funding Petah Tikva, Israel Founded 2024
Website ↗
Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2024
Headcount
6
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences

About

PeptiCore is focusing on development of break-through innovations of anti-bacterial drugs. The first product PheLiz, is an antibiotic, active against a wide range of bacterial and fungal species, with a unique structure making it efficacious on antibiotic-resistant microbial strains and exhibiting an unprecedented resilience to microbial resistance.

The company is a subsidary of Tarom Innovative Technologies.

Q&A

What is Pepticore's primary focus?
Pepticore is focused on the development of breakthrough innovations in anti-bacterial drugs, specifically targeting antibacterial and antifungal drug development.
When was Pepticore founded?
Pepticore was founded in February 2024.
What is the name of Pepticore's first product?
Pepticore's first product is PheLiz, an antibiotic active against a wide range of bacterial and fungal species.
What is Pepticore's current funding stage?
Pepticore is currently in the Pre-Funding stage.
Where is Pepticore's headquarters located?
Pepticore's headquarters is located in Petah Tikva, Center District, Israel.
Who are the Co-CEOs of Pepticore?
Dror Melamed and Ronen Sarousi are the Co-CEOs of Pepticore.
What is Pepticore's relationship with Tarom Innovative Technologies?
Pepticore is a subsidiary of Tarom Innovative Technologies.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical Biotechnology
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Tags

bioconvergencemicrobiologyantibioticspharmaceuticals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)